Literature DB >> 16865020

Functionally oriented rehabilitation program for patients with fibromyalgia: preliminary results.

Heidi K Wennemer1, Joanne Borg-Stein, Lorraine Gomba, Bobbi Delaney, Astrid Rothmund, David Barlow, Gail Breeze, Anita Thompson.   

Abstract

OBJECTIVE: To evaluate function and disability in patients with fibromyalgia before and after participation in a functionally oriented, multidisciplinary, 8-wk treatment program.
DESIGN: A total of 23 patients who met American College of Rheumatology criteria for the diagnosis of fibromyalgia were enrolled in the study. Outcome measures included: range of motion, 6-min walk test, a modified Fibromyalgia Impact Questionnaire, a modified SF-36 Physical Functioning Scale, and the Fibromyalgia Health Assessment Questionnaire. Pretreatment and posttreatment scores were analyzed using paired t tests.
RESULTS: All subjects completed the program, and there were no reported injuries. Three subjects failed to complete the survey instruments at the conclusion of the study. Intention to treat analysis including these subjects was carried out but did not significantly change results. For the remaining subjects (n = 20), a significant improvement was found on the Physical Functioning Scale (P = 0.01). Trends toward improvement on the Fibromyalgia Impact Questionnaire (P = 0.40) and Fibromyalgia Health Assessment Questionnaire (P = 0.14) were seen but did not achieve statistical significance. Range of motion testing revealed significant improvements in lumbar spine extension (P < 0.001), straight-leg raise (P < 0.001), cervical spine flexion (P < 0.01), cervical spine rotation (P < 0.05), and cervical spine side bending (P < 0.05). Distance traveled during the 6-min walk test increased significantly (P < 0.01), whereas perceived exertion as measured by the Borg scale did not change. There were no injuries or other adverse consequences of the program.
CONCLUSIONS: This study utilized multiple functional outcome measures to demonstrate improved function and decreased disability in patients with fibromyalgia. Our patients reported significantly improved physical function after participation in the 8-wk intensive multidisciplinary treatment program. This progressive, functionally based exercise training program was well tolerated by all participants and outlines an effective exercise prescription for patients with fibromyalgia. Fibromyalgia patients in this study responded favorably to a treatment program that focused on function instead of pain.

Entities:  

Mesh:

Year:  2006        PMID: 16865020     DOI: 10.1097/01.phm.0000228677.46845.b2

Source DB:  PubMed          Journal:  Am J Phys Med Rehabil        ISSN: 0894-9115            Impact factor:   2.159


  5 in total

1.  A preliminary survey of the practice patterns of United States Guild Certified Feldenkrais PractitionersCM.

Authors:  Patricia A Buchanan
Journal:  BMC Complement Altern Med       Date:  2010-04-01       Impact factor: 3.659

2.  Early experience with a brief, multimodal, multidisciplinary treatment program for fibromyalgia.

Authors:  Ann Vincent; Mary O Whipple; Terry H Oh; Janet A Guderian; Debra L Barton; Connie A Luedtke
Journal:  Pain Manag Nurs       Date:  2011-07-02       Impact factor: 1.929

3.  The effect of low-frequency sound stimulation on patients with fibromyalgia: a clinical study.

Authors:  Lili Naghdi; Heidi Ahonen; Pasqualino Macario; Lee Bartel
Journal:  Pain Res Manag       Date:  2014-12-29       Impact factor: 3.037

Review 4.  Differences in Multidisciplinary and Interdisciplinary Treatment Programs for Fibromyalgia: A Mapping Review.

Authors:  Emanuele Maria Giusti; Gianluca Castelnuovo; Enrico Molinari
Journal:  Pain Res Manag       Date:  2017-05-23       Impact factor: 3.037

5.  The Impact of Auricular Vagus Nerve Stimulation on Pain and Life Quality in Patients with Fibromyalgia Syndrome.

Authors:  Nazlı Kutlu; Ali Veysel Özden; Hasan Kerem Alptekin; Jülide Öncü Alptekin
Journal:  Biomed Res Int       Date:  2020-02-28       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.